Literature DB >> 9649006

Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis.

D A de Luis1, C Varela, H de La Calle, R Cantón, C M de Argila, A L San Roman, D Boixeda.   

Abstract

Infection by viral or bacterial pathogens has been suspected in playing a role in the development of autoimmune thyroid disease. Because Helicobacter pylori might be involved in the development of nongastrointestinal conditions such as rosacea, ischemic heart disease, and diabetes mellitus, we evaluated the prevalence of H. pylori infection in patients with autoimmune thyroid disease. Fifty-nine patients with autoimmune thyroid disease were included: autoimmune atrophic thyroiditis (n=21), Hashimoto's thyroiditis (n=18), and Graves' disease (n=20). Twenty patients with nontoxic multinodular goiter served as controls for nonautoimmune thyroid disease, and 11 patients with Addison's disease served as controls for nonthyroid endocrine autoimmune disease. The levels of anti-H. pylori immunoglobulin G (IgG) were determined, and a radiolabeled urea breath test were performed. The prevalence of H. pylori infection was markedly increased in the patients with autoimmune atrophic thyroiditis (85.7%), compared with the controls with nontoxic multinodular goiter (40%) and Addison's disease (45.4%). Infection by H. pylori resulted in increased levels of gastrin, pepsinogen I, and pepsinogen II in the H. pylori-positive groups, compared with the H. pylori-negative groups. A positive linear regression was found between the levels of microsomal autoantibodies and those of anti-H. pylori IgG in patients with autoimmune atrophic thyroiditis (n=21; r=0.79; p < 0.01). Finally, and although the overall prevalence of H. pylori infection was not increased, the anti-H. pylori IgG levels and the results from the breath test were higher in the patients with Graves' disease and Hashimoto's thyroiditis patients than in the controls. Clearly, the prevalence of H. pylori infection is increased in autoimmune atrophic thyroiditis and results in abnormalities of gastric secretory function. The strong relation between the levels of anti-H. pylori IgG and the levels of microsomal antibodies suggests that H. pylori antigens might be involved in the development of autoimmune atrophic thyroiditis or that autoimmune function in autoimmune atrophic thyroiditis may increase the likelihood of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649006     DOI: 10.1097/00004836-199806000-00008

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  22 in total

Review 1.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

2.  Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.

Authors:  Kingo Fujimura; Masataka Kuwana; Yoshiyuki Kurata; Masahiro Imamura; Hiroshi Harada; Hisashi Sakamaki; Masanao Teramura; Kyuhei Koda; Shosaku Nomura; Sayaka Sugihara; Takeshi Shimomura; Tetsuro-Takahiro Fujimoto; Kazuma Oyashiki; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 3.  Helicobacter pylori infection and idiopathic thrombocytopenic purpura.

Authors:  Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

4.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 5.  Molecular mimicry and autoimmune thyroid disease.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

6.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

7.  Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.

Authors:  Keiko Ando; Takashi Shimamoto; Tetsuzo Tauchi; Yoshikazu Ito; Yuzuru Kuriyama; Akihiko Gotoh; Keisuke Miyazawa; Yukihiko Kimura; Takashi Kawai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

Review 8.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

9.  Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura.

Authors:  Erdal Kurtoglu; Ertugrul Kayacetin; Aysegul Ugur
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

10.  Alopecia areata is not associated with Helicobacter pylori.

Authors:  Hisham Zayan Abdel Hafez; Ayman Mohamed Mahran; Eman M Hofny; Dalia Abdel Aziz Attallah; Doaa Sameer Sayed; Heba Rashed
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.